12:00 AM
May 31, 2010
 |  BC Week In Review  |  Company News  |  Other News

Qiagen, Roche diagnostic news

Qiagen and Roche's Roche Molecular Systems Inc. unit settled a dispute over distribution rights to TheraScreen companion diagnostics from Qiagen's DxS Ltd. subsidiary. Roche maintains its rights to distribute EGFR and K-Ras assays under the DxS TheraScreen label, and Qiagen obtains...

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >